ArticleGlobal translational medicine2025
CoreView imaging on needle: Rapid core-needle biopsy imaging for point-of-care breast cancer diagnosis.
Article in Global translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated mRNA-Based Detection of ER, PR, HER2, and Ki-67 in Breast Cancer Tissue and Cytology Samples in Resource-Limited Settings.Cancer medicine · 2026Article
- Evaluating the impacts of previous breast surgery on surgical complications and aesthetic outcomes in reverse-sequence endoscopic-assisted nipple-sparing mastectomy with or without direct-to-implant breast reconstruction.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Breast cancer (BC) is one of the most prevalent malignancies worldwide, with early and rapid diagnosis playing a critical role in improving patient outcomes. Core-needle biopsies (CNBs) are the current gold standard for minimally invasive BC diagnoses. However, in low-resource and rural settings, access to CNB diagnostics is limited by infrastructural constraints, long histopathology turnaround times, as well as financial and geographical barriers. To address these challenges, we developed the CoreView imaging on needle (ION), an affordable, integrated imaging system designed to provide rapid, and point-of-care diagnostic assessment of CNB samples. The CoreView ION integrates microscopy with ultraviolet surface excitation technology, enabling the imaging of tissue biopsy surfaces within 5 min, significantly reducing diagnostic delays. This study presents the design, fabrication, and verification of the CoreView ION prototype operation, including its imaging workflow, staining protocols, and tissue compression testing. Our results demonstrate that the system can successfully generate histology-grade images of porcine and murine fresh biopsies, preserving cellular and nuclear detail of normal and tumor tissue. By streamlining CNB imaging and incorporating mainly manual low-cost components, the CoreView ION has the potential to improve BC diagnostics in low-resource settings, ultimately enhancing early detection and patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.